fluconazole has been researched along with Acute Hepatic Failure in 3 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the mechanisms responsible for acute liver failure (ALF) have not yet been fully elucidated, studies have indicated that intrahepatic macrophage activation plays an important role in the pathogenesis of ALF through intrahepatic microcirculatory disorder and consequent parenchymal cell death." | 1.40 | Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats. ( Enjoji, M; Kato, M; Kotoh, K; Masaki, Y; Miyazaki, M; Nakamuta, M; Takayanagi, R; Tanaka, K; Tanaka, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, M | 1 |
| Tanaka, K | 1 |
| Masaki, Y | 1 |
| Miyazaki, M | 1 |
| Kato, M | 1 |
| Kotoh, K | 1 |
| Enjoji, M | 1 |
| Nakamuta, M | 1 |
| Takayanagi, R | 1 |
| Whitney, J | 1 |
| Hurwitz, M | 1 |
| Mojtahed, A | 1 |
| Hwang, C | 1 |
| Gallo, A | 1 |
| Fisher, NC | 1 |
| Cooper, MA | 1 |
| Hastings, JG | 1 |
| Mutimer, DJ | 1 |
3 other studies available for fluconazole and Acute Hepatic Failure
| Article | Year |
|---|---|
Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats.
Topics: Aldehydes; Animals; Apoptosis; Caspase 3; Disease Models, Animal; Fluconazole; Galactosamine; Hepato | 2014 |
Acute liver failure in a pediatric patient with disseminated tuberculosis.
Topics: Antifungal Agents; Antitubercular Agents; Child; Coccidioidomycosis; Drug Therapy, Combination; Etha | 2011 |
Fungal colonisation and fluconazole therapy in acute liver disease.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Liver Fail | 1998 |